We are live on ! Find out more
Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $34.8B
1-Year Est. Return 20.7%
This Fund
S&P 500
This Quarter Est. Return
+7.46%
1 Year Est. Return
+20.7%
3 Year Est. Return
+66.64%
5 Year Est. Return
+79.21%
10 Year Est. Return
+192.59%
AUM
$29.6B
AUM Growth
+$2.54B
Cap. Flow
+$740M
Cap. Flow %
2.5%
Top 10 Hldgs %
36.41%
Holding
1,385
New
83
Increased
652
Reduced
368
Closed
52

Top Buys

Rank Stock Value
1
CRWD icon
CrowdStrike
CRWD
+$163M
2
NOW icon
ServiceNow
NOW
+$139M
3
ELS icon
Equity Lifestyle Properties
ELS
+$137M
4
CCI icon
Crown Castle
CCI
+$118M
5
NFLX icon
Netflix
NFLX
+$115M

Sector Composition

Rank Sector Weight
1 Technology 30%
2 Real Estate 28.67%
3 Communication Services 10.86%
4 Consumer Discretionary 6.91%
5 Financials 5.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TYRA icon
1276
Tyra Biosciences
TYRA
$1.84B
$2K ﹤0.01%
173
VGSH icon
1277
Vanguard Short-Term Treasury ETF
VGSH
$29.3B
$2K ﹤0.01%
41
-257
-86% -$15.1K
ZVRA icon
1278
Zevra Therapeutics
ZVRA
$575M
$2K ﹤0.01%
182
AVBP icon
1279
ArriVent BioPharma
AVBP
$1.4B
$2K ﹤0.01%
111
ORKA
1280
Oruka Therapeutics
ORKA
$5.46B
$2K ﹤0.01%
116
ALEC icon
1281
Alector
ALEC
$169M
$1K ﹤0.01%
277
ALLO icon
1282
Allogene Therapeutics
ALLO
$573M
$1K ﹤0.01%
535
ALT icon
1283
Altimmune
ALT
$581M
$1K ﹤0.01%
235
AMRN
1284
Amarin Corp
AMRN
$293M
$1K ﹤0.01%
66
ANNX icon
1285
Annexon
ANNX
$814M
$1K ﹤0.01%
352
ATXS
1286
DELISTED
Astria Therapeutics
ATXS
$1K ﹤0.01%
186
AURA icon
1287
Aura Biosciences
AURA
$729M
$1K ﹤0.01%
165
AUTL
1288
Autolus Therapeutics
AUTL
$386M
$1K ﹤0.01%
575
AVIR icon
1289
Atea Pharmaceuticals
AVIR
$361M
$1K ﹤0.01%
242
BCYC
1290
Bicycle Therapeutics
BCYC
$275M
$1K ﹤0.01%
103
CDXS icon
1291
Codexis
CDXS
$136M
$1K ﹤0.01%
269
CGEM icon
1292
Cullinan Oncology
CGEM
$1.07B
$1K ﹤0.01%
218
DSGN icon
1293
Design Therapeutics
DSGN
$741M
$1K ﹤0.01%
100
-250
-71% -$1.25K
EDIT icon
1294
Editas Medicine
EDIT
$402M
$1K ﹤0.01%
277
HCM icon
1295
HUTCHMED
HCM
$1.93B
$1K ﹤0.01%
85
HUMA icon
1296
Humacyte
HUMA
$170M
$1K ﹤0.01%
301
IEUR icon
1297
iShares Core MSCI Europe ETF
IEUR
$8.82B
$1K ﹤0.01%
18
IRWD icon
1298
Ironwood Pharmaceuticals
IRWD
$626M
$1K ﹤0.01%
573
LYEL icon
1299
Lyell Immunopharma
LYEL
$318M
$1K ﹤0.01%
45
MRVI icon
1300
Maravai LifeSciences
MRVI
$1.01B
$1K ﹤0.01%
490

Similar funds

Daiwa Securities Group's Q3 2025 Portfolio in Review

As of Q3 2025, Daiwa Securities Group held 1,385 positions worth $29.6B, up 9.4% from $27.1B the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Daiwa Securities Group's Q3 2025 filing shows 83 new, 652 increased, 368 reduced and 52 closed positions. Its largest new stake was Eagle Materials: 54,795 shares worth $12.8M. The largest sale was Global X Conscious Companies ETF, an estimated $130M.

By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 28% a quarter earlier, followed by Real Estate and Communication Services.

  • Daiwa Securities Group's largest Q3 2025 buy was Eagle Materials: 54,795 shares worth $12.8M.
  • Daiwa Securities Group added most to CrowdStrike in Q3 2025, an estimated $163M increase.
  • Daiwa Securities Group's biggest Q3 2025 reduction was Global X Conscious Companies ETF, cutting an estimated $130M.
  • Daiwa Securities Group fully exited Ansys in Q3 2025, selling an estimated $6.94M.
  • Daiwa Securities Group's ten largest holdings make up 36% of its $29.6B portfolio in Q3 2025.
  • Daiwa Securities Group opened 83 new positions and closed 52 in Q3 2025.
  • Daiwa Securities Group's portfolio value rose 9.4% quarter-over-quarter to $29.6B.

Based on Daiwa Securities Group's 13F filing for Q3 2025, filed 14 Nov 2025.